Elizabeth Jungman

Elizabeth Jungman
Elizabeth Jungman
Public Health
The Pew Charitable Trusts


Elizabeth Jungman directs Pew’s work on public health, overseeing initiatives related to the innovation of antibiotics and the safety of prescription drugs, over-the-counter medicines, and other consumer health care products.

Before joining Pew, Jungman was a senior health policy adviser with the U.S. Senate Committee on Health, Education, Labor, and Pensions, where she played a key role in drafting and negotiating the Food and Drug Administration Safety and Innovation Act of 2012 and other health- and drug-related legislation, including pandemic preparedness, drug compounding, and supply chain security measures. Previously, she was in private legal practice, counseling clients on a broad range of FDA regulatory matters and other health care issues. Jungman serves on FDA’s Pharmacy Compounding Advisory Committee.

She has a bachelor’s degree in biology from Harvard College, a master’s in public health from Johns Hopkins University, and a Juris Doctor from Georgetown University.

Recent Work